Concepedia

Danielle Ulanet

DU

15

Publications

1.6K

Citations

14

H-Index

1999

Active since

Affiliations

Johns Hopkins University(Current)

University of California, San Francisco

Johns Hopkins Medicine

Agios Pharmaceuticals (United States)

Memorial Sloan Kettering Cancer Center

Danielle Ulanet is an author at Johns Hopkins University specializing in medicine, cell biology, and cancer research.

ORCID

Top concepts

Publications per year

1999–2023

15

Publications

15

Cleavage by Granzyme B Is Strongly Predictive of Autoantigen Status

Livia Casciola‐Rosen, Felipe Andrade, Danielle Ulanet et al. · The Journal of Experimental Medicine · 1999 · 486 citations · Full text

Transformation-Associated Changes in Sphingolipid Metabolism Sensitize Cells to Lysosomal Cell Death Induced by Inhibitors of Acid Sphingomyelinase

Nikolaj H.T. Petersen, Ole Dines Olsen, Line Groth‐Pedersen et al. · Cancer Cell · 2013 · 330 citations · Full text

, , +11

Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy

Danielle Ulanet, Dale L. Ludwig, C. Ronald Kahn et al. · Proceedings of the National Academy of Sciences · 2010 · 232 citations · Full text

Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results

Timothy A. Yap, Elisa Fontana, Elizabeth K. Lee et al. · Nature Medicine · 2023 · 94 citations · Full text

Differential Aspartate Usage Identifies a Subset of Cancer Cells Particularly Dependent on OGDH

Eric L. Allen, Danielle Ulanet, David Pirman et al. · Cell Reports · 2016 · 66 citations · Full text

Rows per page

1–5 of 15